SCENARIO ANALYSIS OF THE FUTURE OF MEDICINES

被引:18
作者
LEUFKENS, H
HAAIJER-RUSKAMP, FM
BAKKER, A
DUKES, G
机构
[1] UNIV GRONINGEN, INST DRUG STUDIES, 9713 AV GRONINGEN, NETHERLANDS
[2] WORLD BANK, DEPT PHN PHARMACEUT, WASHINGTON, DC 20433 USA
关键词
D O I
10.1136/bmj.309.6962.1137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Planning future policy for medicines poses difficult problems. The main players in the drug business have their own views as to how the world around them functions and how the future of medicines should be shaped. In this paper we show how a scenario analysis can provide a powerful teaching device to readjust peoples' preconceptions. Scenarios are plausible, not probable or preferable, portraits of alternative futures. A series of four of alternative scenarios were constructed: ''sobriety in sufficiency,'' ''risk avoidance,'' ''technology on demand,'' and ''free market unfettered.'' Each scenario was drawn as a narrative, documented quantitatively wherever possible, that described the world as it might be if particular trends were to dominate development. The medical community and health policy makers may use scenarios to take a long term view in order to be prepared adequately for the future.
引用
收藏
页码:1137 / 1140
页数:4
相关论文
共 14 条
[1]  
Dukes M N G., 1993, WHO REGIONAL PUBLICA, V45
[2]  
DUKES MNG, 1991, POSTMARKETING SURVEI, V5, P231
[3]   CONFERENCE - SCENARIO ANALYSIS OF THE FUTURE OF MEDICINES [J].
FOLB, PI .
LANCET, 1993, 342 (8866) :294-294
[4]   TOWARDS RATIONAL PRESCRIBING [J].
GILLEY, J .
BRITISH MEDICAL JOURNAL, 1994, 308 (6931) :731-732
[5]  
GRABOWSKI H, 1991, 1991 CMR ANN LECT CA
[6]  
GRIFFIN MT, 1991, AM J LAW MED, V17, P363
[7]  
LEUFKENS HGM, 1993, LANCET, V342, P1178
[8]   EVALUATING DRUGS AFTER THEIR APPROVAL FOR CLINICAL USE [J].
RAY, WA ;
GRIFFIN, MR ;
AVORN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (27) :2029-2032
[9]  
Schwartz P., 1991, ART LONG VIEW
[10]   MEDICINE IN EUROPE - PRESCRIBING IN EUROPE - FORCES FOR CHANGE .8. [J].
TAYLOR, D .
BRITISH MEDICAL JOURNAL, 1992, 304 (6821) :239-242